Archean Chemical FY26 Net Profit Rs 15,437 Lakh; Rs 2.50 Dividend Declared

Archean Chemical Industries Limited announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a standalone net profit of Rs 2,976.16 lakh for the quarter ended March 31, 2026, compared to Rs 5,830.74 lakh in the corresponding quarter of the previous year. For the full year, the standalone net profit stood at Rs 15,437.29 lakh, down from Rs 18,492.34 lakh in the previous year. Revenue from operations for the year was Rs 1,04,153.98 lakh, a slight increase from Rs 1,01,379.02 lakh in the previous year. The board has recommended a final dividend of Rs 2.50 per equity share of Rs 2 each (125%) for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming Annual General Meeting (AGM). Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published its financial results in Business Standard (English) and Makkal Kural (Tamil edition) on May 13, 2026.

Financial Performance

The board approved the audited standalone and consolidated financial results at its meeting held on May 11, 2026. On a consolidated basis, net profit for the year ended March 31, 2026, was Rs 10,540.80 lakh, compared to Rs 16,214.49 lakh in the previous year. Total consolidated income for the year was Rs 1,10,799.98 lakh. The company noted that the previous year's results included an exceptional loss of Rs 4,018.27 lakh due to the impact of cyclone Asna on industrial salt stock. The following table summarises the key financial metrics across standalone and consolidated bases:

Metric Standalone FY26 (Rs in Lakh) Standalone FY25 (Rs in Lakh) Consolidated FY26 (Rs in Lakh) Consolidated FY25 (Rs in Lakh) Revenue from Operations 1,04,153.98 1,01,379.02 1,08,105.07 1,04,101.79 Total Income 1,08,875.06 1,06,344.54 1,10,799.98 1,07,830.09 Net Profit 15,437.29 18,492.34 10,540.80 16,214.49 EPS – Basic 12.51 14.98 8.67 13.13 EPS – Diluted 12.50 14.97 8.66 13.12

Governance and Appointments

The board re-appointed M/S. PKF Sridhar & Santhanam LLP, Chartered Accountants, as statutory auditors for a second term of four consecutive years, effective from the conclusion of the 17th AGM until the conclusion of the 21st AGM to be held in 2030, subject to member approval. Additionally, the board re-appointed Mr. Kandheri Munuswamy Mohandass (DIN: 00707839) and Mr. Chittoor Ghatambu Sethuram (DIN: 01081951) as Independent Directors for a second term of five consecutive years commencing from December 06, 2026, to December 05, 2031, subject to shareholder approval.

The 17th AGM has been scheduled via Video Conferencing or Other Audio-Visual Means on Friday, June 12, 2026. The company also announced an earnings call on May 13, 2026, at 02:00 PM IST to discuss the operational and financial performance for the quarter and year ended March 31, 2026.

Archean Chemical Industries reported a steep year-on-year decline in profitability in Q4FY26, even as full-year consolidated revenue posted modest growth. The company's Q4FY26 consolidated net profit (Profit After Tax) fell to ₹122.3mn from ₹537.5mn in Q4FY25, reflecting significant pressure on the bottom line. Consolidated total income for Q4FY26 came in at ₹3,063.3mn, compared to ₹3,533.8mn in the year-ago quarter. For the full year FY26, consolidated total income grew 8% year-on-year to ₹11,740.2mn from ₹10,912.4mn in FY25. In a regulatory filing, the company announced that the audio recording of the earnings conference call held on May 13, 2026, is now available on its website.

Q4FY26 & FY26 Consolidated Financial Performance

Operational profitability saw a sharp contraction during Q4FY26. Consolidated EBITDA declined to ₹490.8mn from ₹961.0mn on a year-on-year basis. Finance costs rose sharply to ₹104.3mn in Q4FY26 from ₹2.9mn in Q4FY25, weighing heavily on the bottom line. For the full year FY26, consolidated EBITDA stood at ₹2,657.3mn against ₹3,514.4mn in FY25, while consolidated PAT for FY26 was ₹1,054.1mn compared to ₹1,621.4mn in FY25. The following table summarizes the key consolidated financial metrics:

Metric: Q4FY26 Q4FY25 FY26 FY25 Total Income: ₹3,063.3mn ₹3,533.8mn ₹11,080.0mn ₹10,783.0mn EBITDA: ₹490.8mn ₹961.0mn ₹2,657.3mn ₹3,514.4mn Profit Before Tax: ₹158.6mn ₹746.7mn ₹1,471.0mn ₹2,639.5mn Profit After Tax: ₹122.3mn ₹537.5mn ₹1,054.1mn ₹1,621.4mn Basic EPS (₹): 1.13 4.33 8.66 13.13

Standalone Performance

On a standalone basis, Archean Chemical's Q4FY26 total income stood at ₹3,047.1mn versus ₹3,333.3mn in Q4FY25. Standalone EBITDA for Q4FY26 came in at ₹664.0mn compared to ₹1,011.2mn in Q4FY25. Standalone PAT for Q4FY26 was ₹297.6mn, down from ₹583.1mn in Q4FY25. For the full year FY26, standalone total income was ₹10,887.5mn against ₹10,634.5mn in FY25, while standalone PAT stood at ₹1,543.7mn compared to ₹1,849.2mn in FY25.

Metric: Q4FY26 Q4FY25 FY26 FY25 Total Income: ₹3,047.1mn ₹3,333.3mn ₹10,887.5mn ₹10,634.5mn EBITDA: ₹664.0mn ₹1,011.2mn ₹3,080.4mn ₹3,721.2mn Profit Before Tax: ₹419.0mn ₹795.8mn ₹2,102.6mn ₹2,899.5mn Profit After Tax: ₹297.6mn ₹583.1mn ₹1,543.7mn ₹1,849.2mn Basic EPS (₹): 2.41 4.72 12.51 14.98

Subsidiary-wise Revenue and Profitability Contribution

The consolidated performance was supported by strong revenue growth from subsidiaries, particularly ACUME Chemicals, which reported total income of ₹830.5mn in FY26 versus ₹274.7mn in FY25, a growth of 202% year-on-year. The parent entity ACIL contributed ₹10,887.5mn in FY26, up 2% from ₹10,634.5mn in FY25. NEUN reported income of ₹5.2mn in FY26 against ₹2.7mn in FY25, a growth of 89%. However, at the EBITDA level, subsidiaries ACUME, IDEALIS, and NEUN remained loss-making, with ACUME reporting EBITDA of ₹-98.3mn in FY26 versus ₹-4.3mn in FY25, and IDEALIS reporting ₹-47.8mn versus ₹-75.8mn in FY25.

Entity: FY26 Total Income FY25 Total Income YoY Growth FY26 EBITDA FY26 PBT ACIL: ₹10,887.5mn ₹10,634.5mn 2% ₹3,080.4mn ₹2,102.6mn ACUME: ₹830.5mn ₹274.7mn 202% ₹-98.3mn ₹-421.8mn IDEALIS: ₹17.0mn ₹0.5mn — ₹-47.8mn ₹-150.4mn NEUN: ₹5.2mn ₹2.7mn 89% ₹-33.4mn ₹-46.9mn Consolidated Total Income: ₹11,740.2mn ₹10,912.4mn 8%

Silicon Carbide Semiconductor Facility: A Strategic Milestone

A key strategic development highlighted in the investor presentation is the progress on Archean's semiconductor ambitions. The company's subsidiary, SiCSem Private Limited, conducted a Bhoomi Pujan and Groundbreaking ceremony in November 2025 to establish an integrated Silicon Carbide (SiC)-based Compound Semiconductor fab and ATMP Unit in Info Valley, Bhubaneswar, Odisha. The facility has been approved by the Cabinet under the Indian Semiconductor Mission (ISM) and is positioned as the first commercial compound fab in the country. The project is being developed in collaboration with Clas-Sic Wafer Fab Limited, UK, in which Archean Chemical holds a 21% stake.

Parameter: Details Entity: SiCSem Private Limited (step-down subsidiary of ACIL) Product: Silicon Carbide (SiC) devices – MOSFETs and Power Devices Annual Wafer Capacity: 60,000 wafers Packaging Capacity: 96 million units Location: Info Valley, Bhubaneswar, Odisha Collaboration: Clas-Sic Wafer Fab Limited, UK (ACIL holds 21% stake) End Users: Defence, EVs, Railway, Fast Chargers, Data Centres, Consumer Appliances, Solar Power Inverters

Consolidated Balance Sheet Highlights

As of March 26, consolidated total assets stood at ₹26,647.8mn compared to ₹23,890.3mn as of March 25. Shareholders' funds increased to ₹19,343.9mn from ₹18,640.1mn. Current borrowings rose significantly to ₹2,783.5mn from ₹264.7mn, contributing to an increase in current liabilities to ₹4,383.5mn from ₹1,972.8mn. Non-current borrowings declined to ₹1,266.7mn from ₹1,516.0mn over the same period. Cash and cash equivalents stood at ₹412.3mn as of March 26 versus ₹405.4mn as of March 25.

Balance Sheet Item: Mar-26 Mar-25 Total Assets: ₹26,647.8mn ₹23,890.3mn Shareholders' Funds: ₹19,343.9mn ₹18,640.1mn Non-Current Borrowings: ₹1,266.7mn ₹1,516.0mn Current Borrowings: ₹2,783.5mn ₹264.7mn Cash & Cash Equivalents: ₹412.3mn ₹405.4mn Total Equity & Liabilities: ₹26,647.8mn ₹23,890.3mn

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.